Amgen Inc. (AMGN) — Fair Value Analysis

Base-case fair value (P50): $427.14 · Current price: $425.28 · Verdict: Fairly Valued

The Verdict on AMGN

Amgen Inc (AMGN) is currently assessed as Fairly Valued based on our Monte Carlo simulations. With the stock trading at $425.28, our analysis indicates a median fair value (P50) of $427.14. This narrow gap translates to an +0.4% against the current trading price, signaling that the market is largely reflecting AMGN's intrinsic value. This valuation aligns with Amgen's operational and financial health, which our models categorize as an average quality tier within its broader market context. Investors should note this tight alignment between market price and simulated fair value.

How AMGN stacks up against peers

AMGN's average quality tier suggests a balanced operational and financial profile, neither significantly outperforming nor underperforming its relevant industry metrics. The congruence between its $425.28 and the $427.14 further reinforces this perspective, indicating a company whose current valuation is well-supported by fundamental projections. While a marginal +0.4% is present, it does not suggest a substantial mispricing or a compelling deep-value opportunity compared to other companies that might show greater discrepancies between market price and fair value. This close resemblance hints at efficient market pricing for AMGN given its current fundamentals.

What this means for investors

For investors, AMGN's Fairly Valued status, with its $425.28 almost perfectly matching the $427.14, implies that the stock may not offer significant immediate arbitrage opportunities from a pure valuation perspective. Our Monte Carlo models have thoroughly explored thousands of forward scenarios, yielding this robust median fair value. While investors might anticipate a bull case or prepare for a downside scenario, these would typically necessitate fundamental shifts beyond the current projections that underpin the $427.14. To understand the full range of potential outcomes for AMGN, including the comprehensive bear and bull distribution and to track its fair value as new fundamentals are released, sign up for a free FairCurve account.